ANDREA SHELLY: Open Payments
NPI 1326558156 · EPHRATA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 30 payments from 7 companies in 2025. Trend: 2023 $1,864 · 2024 $648 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $294 |
| Madrigal Pharmaceuticals | 4 | $181 |
| ABBVIE INC. | 11 | $171 |
| Janssen Biotech, Inc. | 5 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Ardelyx, Inc. | 1 | $29 |
| Celltrion USA Inc. | 1 | $24 |
Products named: DUPIXENT, REZDIFFRA, TREMFYA, RINVOQ, ENTYVIO, LINZESS, IBSRELA, VEGZELMA.
Industry payments across PA — which companies pay providers there.
